01 1DARMERICA, LLC
02 1DSP
03 1Fagron Inc
04 2ION EXCHANGE INDIA LIMITED
05 1LETCO MEDICAL, LLC
06 1Medisca Inc.
07 1PUROLITE S.R.L
08 1Professional Compounding Centers of America dba PCCA
09 1Spectrum Laboratory Products, Inc
01 2CHOLESTYRAMINE
02 2CHOLESTYRAMINE RESIN
03 2Cholestyramine
04 4Cholestyramine Resin
01 2India
02 1Netherlands
03 4U.S.A
04 2United Kingdom
05 1Blank
NDC Package Code : 71052-151
Start Marketing Date : 2019-06-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5000g/5000g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0684
Start Marketing Date : 1998-04-01
End Marketing Date : 2027-10-15
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 55363-454
Start Marketing Date : 2012-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55363-454
Start Marketing Date : 2012-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2650
Start Marketing Date : 2011-02-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0822
Start Marketing Date : 2009-01-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-4962
Start Marketing Date : 2016-09-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (90kg/90kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 68444-0001
Start Marketing Date : 2010-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (90kg/90kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-2011
Start Marketing Date : 1999-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53933-2175
Start Marketing Date : 1998-10-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Cholestyramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholestyramine, including repackagers and relabelers. The FDA regulates Cholestyramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholestyramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cholestyramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cholestyramine supplier is an individual or a company that provides Cholestyramine active pharmaceutical ingredient (API) or Cholestyramine finished formulations upon request. The Cholestyramine suppliers may include Cholestyramine API manufacturers, exporters, distributors and traders.
click here to find a list of Cholestyramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cholestyramine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cholestyramine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cholestyramine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cholestyramine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cholestyramine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cholestyramine suppliers with NDC on PharmaCompass.
We have 8 companies offering Cholestyramine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
